ClinicalTrials.Veeva

Menu

: Association of Melatonin Levels and Light and Noise Isolation in ICU

D

Diskapi Yildirim Beyazit Training and Research Hospital

Status

Completed

Conditions

Cranial Nerve Diseases

Treatments

Other: Group Isolated

Study type

Interventional

Funder types

Other

Identifiers

NCT03659760
EmineMelatonin

Details and patient eligibility

About

Melatonin is secreted from the epiphyseal gland with a circadian rhythm and is known to be anti-inflammatory.

In this study, it is planned to investigate the effect of sleep disruptions on melatonin levels and inflammation parameters in intensive care patients underwent transcranial surgery

Full description

Patients with Glasgow coma scale (GKS) >14, American Society of Anesthesiologist (ASA) I-III, intensive care patients underwent transcranial surgery will be included

Patients will be randomly allocated by a computer generated random numbers list into two groups.

Patients with sleep disruptions (Group I) (exposed to ambient light and noise) and Patients without sleep disruptions (Group II) (eyes closed with patch and ear plugged; between 24:00-06:00)

Melatonin levels will be measured by urine 6-sulfatoxymelatonin (a-MT6) levels, which is a product of melatonin degradation at 07:00 am preoperative and postoperative day 1 and day 3.

Plasma Interleukin-1 (IL-1), Interleukin- 6 (IL-6),C-reactive protein (CRP) levels will be measured at 07:00 am preoperative and postoperative day 1and day 3.

Enrollment

41 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • ASA 1-3
  • Glasgow Coma Scale(GCS) >14

Exclusion Criteria:

  • Glasgow Coma Scale(GCS) <14
  • Patients who do not understand the questions, not awake
  • Patient who treated with hormones
  • Patient with infection or inflammatory disease

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

41 participants in 2 patient groups

Group Isolated
Experimental group
Description:
Group Isolated (Group II) (eyes closed with patch and ear plugged; between 24:00-06:00)
Treatment:
Other: Group Isolated
Group Disrupted
No Intervention group
Description:
Group Disrupted (Group I) (exposed to ambient light and noise)

Trial contacts and locations

1

Loading...

Central trial contact

Emine Arık; Emine Arık

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems